CSL PHARMA-ADVICE ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About CSL PHARMA-ADVICE ApS
CSL PHARMA-ADVICE ApS (CVR number: 36501693) is a company from LEJRE. The company recorded a gross profit of 30.6 kDKK in 2022. The operating profit was 30.6 kDKK, while net earnings were 32.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 14.7 %, which can be considered good but Return on Equity (ROE) was 16.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 95.3 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. CSL PHARMA-ADVICE ApS's liquidity measured by quick ratio was 21.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsNet sales (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 399.61 | 261.33 | 143.18 | ||
Gross profit | 280.54 | 180.52 | 94.98 | -34.69 | 30.60 |
EBIT | 280.54 | 180.52 | 94.98 | -34.69 | 30.60 |
Net earnings | 214.34 | 134.58 | 70.72 | -44.53 | 32.50 |
Shareholders equity total | 545.62 | 480.20 | 420.91 | 266.39 | 133.89 |
Balance sheet total (assets) | 589.61 | 555.60 | 449.54 | 276.56 | 140.52 |
Net debt | - 582.15 | - 538.83 | - 426.22 | - 273.51 | - 127.48 |
Profitability | |||||
EBIT-% | 70.2 % | 69.1 % | 66.3 % | ||
ROA | 44.1 % | 31.5 % | 18.9 % | -9.6 % | 14.7 % |
ROE | 38.4 % | 26.2 % | 15.7 % | -13.0 % | 16.2 % |
ROI | 51.0 % | 35.2 % | 21.1 % | -10.1 % | 15.3 % |
Economic value added (EVA) | 206.04 | 138.72 | 76.08 | -34.42 | 30.96 |
Solvency | |||||
Equity ratio | 92.5 % | 86.4 % | 93.6 % | 96.3 % | 95.3 % |
Gearing | |||||
Relative net indebtedness % | -134.7 % | -177.3 % | -277.7 % | ||
Liquidity | |||||
Quick ratio | 13.4 | 7.4 | 15.7 | 27.2 | 21.2 |
Current ratio | 13.4 | 7.4 | 15.7 | 27.2 | 21.2 |
Cash and cash equivalents | 582.15 | 538.83 | 426.22 | 273.51 | 127.48 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | 136.5 % | 183.7 % | 294.0 % | ||
Credit risk | |||||
Credit rating | BB | BB | BB | C | B |
Variable visualization
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.